CJ Gelatine Products Limited announced its unaudited financial results for the third quarter and nine months ended December 31, 2025. The Board of Directors approved these results at their meeting held on February 7, 2026, following recommendations from the Audit Committee.

Quarterly Financial Performance

The company's Q3FY26 performance showed mixed results compared to the previous year. Net profit declined significantly to ₹11.07 lakhs from ₹17.15 lakhs in Q3FY25, marking a decrease of 35.4%. Revenue from operations also contracted by 6.6% year-on-year to ₹1020.36 lakhs from ₹1092.68 lakhs.

Nine-Month Performance Shows Recovery

Despite quarterly challenges, the nine-month period demonstrated significant improvement. The company achieved a net profit of ₹1.15 lakhs for the nine months ended December 31, 2025, compared to a loss of ₹2.38 lakhs in the corresponding period of the previous year, marking a complete turnaround.

Operational Cost Analysis

The company's cost structure showed mixed trends during the quarter. Cost of materials consumed increased to ₹844.96 lakhs from ₹830.91 lakhs in Q3FY25. Employee benefit expenses rose to ₹149.44 lakhs compared to ₹140.20 lakhs in the previous year quarter. Finance costs increased to ₹33.70 lakhs from ₹31.22 lakhs year-on-year.

Earnings Per Share Metrics

Earnings per share metrics reflected the quarterly performance decline. Basic and diluted EPS after exceptional items stood at ₹0.23 for Q3FY26 compared to ₹0.36 in Q3FY25.

For the nine-month period, basic and diluted EPS improved to ₹0.024 compared to negative ₹0.049 in the previous year.

Corporate Governance and Compliance

The financial results were prepared in accordance with Indian Accounting Standards (Ind-AS) and reviewed by statutory auditors S P A R K & Associates, Chartered Accountants LLP. The company operates in a single segment of manufacturing gelatine and related by-products. CJ Gelatine Products maintains its paid-up equity share capital at ₹481.33 lakhs with a face value of ₹10 per share.

The results demonstrate the company's resilience in challenging market conditions, with the nine-month turnaround indicating potential for sustained recovery despite quarterly headwinds.

CJ Gelatine Products Limited, a manufacturer of gelatin products, has announced its unaudited financial results for the second quarter and first half of the fiscal year 2026, ending September 30, 2025. The company's Board of Directors approved these results in a meeting held on November 14, 2025.

Financial Performance

According to the company's filing, CJ Gelatine Products Limited reported a net loss across all reported periods. While specific figures were not disclosed in the initial announcement, the company's performance indicates challenging market conditions or operational difficulties.

Key Highlights

• Net Loss: The company reported losses for both the quarter and half-year ended September 30, 2025.
• Board Approval: The financial results were approved by the Board of Directors on November 14, 2025.
• Auditor Review: M/s S P A R K & Associates, Chartered Accountants LLP (FRN: 005313C / C400311), the company's statutory auditors, conducted a limited review of the financial statements.

Regulatory Compliance

The company has complied with regulatory requirements by submitting its unaudited financial results to the BSE Limited, as per Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Looking Ahead

As CJ Gelatine Products Limited navigates through this challenging period, market observers may be keen to see what strategies the company implements to address its financial performance in the coming quarters. The gelatin industry's dynamics and any company-specific factors contributing to the losses could be areas of interest for analysts and investors alike.

Shareholders and potential investors are advised to review the detailed financial statements and any subsequent management discussions to gain a more comprehensive understanding of the company's current position and future outlook.